FRANK BATEMAN: Open Payments
NPI 1831262567 · POTSDAM, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$910 in 53 payments from 10 companies in 2025. Trend: 2023 $588 · 2024 $384 · 2025 $910
Food & beverage: $910
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 24 | $332 |
| PFIZER INC. | 9 | $171 |
| Lilly USA, LLC | 3 | $64 |
| LEO Pharma Inc. | 3 | $58 |
| E.R. Squibb & Sons, L.L.C. | 3 | $58 |
| Novartis Pharmaceuticals Corporation | 3 | $57 |
| ABBVIE INC. | 3 | $54 |
| UCB, Inc. | 2 | $51 |
| Galderma Laboratories, L.P. | 2 | $38 |
| Regeneron Healthcare Solutions, Inc. | 1 | $25 |
Products named: TREMFYA, CIBINQO, TALTZ, ADBRY, Sotyktu, COSENTYX, SKYRIZI, Bimzelx.
Industry payments across NY — which companies pay providers there.
